Haiti

Caribbean

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Haiti is regulated by the MSPP (Ministère de la Santé Publique). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

MSPP (Ministère de la Santé Publique)

Regulatory Pathways (1)

Haiti MOH Special Import Authorization 45 days

Haiti Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Haiti Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Haiti

ISO Code	`HT`
Region	Caribbean
Regulatory Authority	MSPP (Ministère de la Santé Publique)
Pathways	1 documented
Drugs Available	0 documented